42 related articles for article (PubMed ID: 23989288)
1. Derivatives of D(-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis.
Das S; Mondal S; Patel T; Himaja A; Adhikari N; Banerjee S; Baidya SK; De AK; Gayen S; Ghosh B; Jha T
Eur J Med Chem; 2024 Aug; 274():116563. PubMed ID: 38843586
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP).
Cuffaro D; Nuti E; Gifford V; Ito N; Camodeca C; Tuccinardi T; Nencetti S; Orlandini E; Itoh Y; Rossello A
Bioorg Med Chem; 2019 Jan; 27(1):196-207. PubMed ID: 30522899
[TBL] [Abstract][Full Text] [Related]
3. Matrix Metalloproteinase 13 Inhibitors for Modulation of Osteoclastogenesis: Enhancement of Solubility and Stability.
Knapinska AM; Singh C; Drotleff G; Blanco D; Chai C; Schwab J; Herd A; Fields GB
ChemMedChem; 2021 Apr; 16(7):1133-1142. PubMed ID: 33331147
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel heterocyclic MMP inhibitors.
Hayashi R; Jin X; Cook GR
Bioorg Med Chem Lett; 2007 Dec; 17(24):6864-70. PubMed ID: 18029173
[TBL] [Abstract][Full Text] [Related]
5. New Derivatives of
Balakina A; Gadomsky S; Kokovina T; Sashenkova T; Mishchenko D; Terentiev A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003553
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.
Mou J; Fang H; Jing F; Wang Q; Liu Y; Zhu H; Shang L; Wang X; Xu W
Bioorg Med Chem; 2009 Jul; 17(13):4666-73. PubMed ID: 19454370
[TBL] [Abstract][Full Text] [Related]
7. Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors.
Fischer T; Riedl R
ChemMedChem; 2013 Sep; 8(9):1457-61, 1572. PubMed ID: 23894097
[No Abstract] [Full Text] [Related]
8. Structure-Based Optimization and Biological Evaluation of Potent and Selective MMP-7 Inhibitors for Kidney Fibrosis.
Abe-Sato K; Tabuse H; Kanazawa H; Kamitani M; Endo M; Tokura S; Wakabayashi S; Yahara T; Takeda T; Hitaka K; Gunji E; Kojima N; Oka Y
J Med Chem; 2023 Nov; 66(21):14653-14668. PubMed ID: 37861435
[TBL] [Abstract][Full Text] [Related]
9. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
[TBL] [Abstract][Full Text] [Related]
10. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
Rashid ZA; Bardaweel SK
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569509
[TBL] [Abstract][Full Text] [Related]
11. Metal Complexes as Promising Matrix Metalloproteinases Regulators.
Nguyen YT; Kim N; Lee HJ
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674771
[TBL] [Abstract][Full Text] [Related]
12. Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation.
Albelwi FF; Teleb M; Abu-Serie MM; Moaty MNAA; Alsubaie MS; Zakaria MA; El Kilany Y; Aouad MR; Hagar M; Rezki N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638665
[TBL] [Abstract][Full Text] [Related]
13. Design and Synthesis of Water-Soluble and Potent MMP-13 Inhibitors with Activity in Human Osteosarcoma Cells.
Zapico JM; Acosta L; Pastor M; Rangasamy L; Marquez-Cantudo L; Coderch C; Ortin I; Nicolau-Sanus M; Puchades-Carrasco L; Pineda-Lucena A; Majali-Martinez A; Ramos P; de Pascual-Teresa B; Ramos A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576138
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MMP2-PEX by a novel ester of dihydroxy cinnamic and linoleic acid from the seagrass Cymodocea serrulata.
Christina VS; Sundaram RL; Sivamurugan V; Kumar DT; Mohanapriya CD; Shailaja VL; Thyagarajan SP; Doss CGP; Gnanambal KME
Sci Rep; 2021 Jun; 11(1):11451. PubMed ID: 34075089
[TBL] [Abstract][Full Text] [Related]
15. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
[TBL] [Abstract][Full Text] [Related]
16. Progress towards water-soluble triazole-based selective MMP-2 inhibitors.
Fabre B; Filipiak K; Zapico JM; Díaz N; Carbajo RJ; Schott AK; Martínez-Alcázar MP; Suárez D; Pineda-Lucena A; Ramos A; de Pascual-Teresa B
Org Biomol Chem; 2013 Oct; 11(38):6623-41. PubMed ID: 23989288
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Novel Hybrids Inspired from Bromopyrrole Alkaloids Inhibiting MMP-2 and -12 as Antineoplastic Agents.
Rane RA; Naphade SS; Bangalore PK; Palkar MB; Patel HM; Shaikh MS; Alwan WS; Karpoormath R
Chem Biol Drug Des; 2015 Aug; 86(2):210-22. PubMed ID: 25418204
[TBL] [Abstract][Full Text] [Related]
19. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
